Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

Market Cap	4.94B +107.2%
Revenue (ttm)	318.16M -10.9%
Net Income	101.52M +244.9%
EPS	0.14 +234.5%
Shares Out	745.67M
PE Ratio	48.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,638,702
Average Volume	70,422,869
Open	6.80
Previous Close	6.62
Day's Range	6.49 - 6.80
52-Week Range	3.12 - 9.41
Beta	0.27
RSI	39.52
Earnings Date	Apr 25, 2026

About SHE:002370

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 529
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002370

Financial Performance

In 2025, SHE:002370's revenue was 323.14 million, a decrease of -20.25% compared to the previous year's 405.17 million. Earnings were 96.31 million, an increase of 181.27%.